Verrica Pharmaceuticals
VRCA
VRCA
59 hedge funds and large institutions have $84.2M invested in Verrica Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more funds holding
Funds holding: 50 → 59 (+9)
0.46% more ownership
Funds ownership: 2.63% → 3.09% (+0.46%)
Holders
59
Holding in Top 10
–
Calls
$1.32M
Puts
$227K
Top Buyers
| 1 | +$17.2M | |
| 2 | +$1.36M | |
| 3 | +$982K | |
| 4 |
Jane Street
New York
|
+$750K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$617K |
Top Sellers
| 1 | -$6.24M | |
| 2 | -$1.54M | |
| 3 | -$649K | |
| 4 |
CI
Conning Inc
Hartford,
Connecticut
|
-$355K |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$355K |